Patients with Poor Response to Antipsychotics Have a More Severe Pattern of Frontal Atrophy: A Voxel-Based Morphometry Study of Treatment Resistance in Schizophrenia

The social and economic burden of treatment-resistant schizophrenia

(2013) James L. Kennedy et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: Correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses

(2013) Andrea de Bartolomeis et al.   PSYCHIATRY RESEARCH

Association between Psychotic Symptoms and Cortical Thickness Reduction across the Schizophrenia Spectrum

(2012) V. Oertel-Knochel et al.   CEREBRAL CORTEX

Association of Genetic Variants on 15q12 With Cortical Thickness and Cognition in Schizophrenia

(2011) Trygve E. Bakken   ARCHIVES OF GENERAL PSYCHIATRY

Changes in Cortical Thickness During the Course of Illness in Schizophrenia

(2011) Neeltje E. M. van Haren   ARCHIVES OF GENERAL PSYCHIATRY

Long-term Antipsychotic Treatment and Brain Volumes

(2011) Beng-Choon Ho et al.   ARCHIVES OF GENERAL PSYCHIATRY

Progressive Brain Change in Schizophrenia: A Prospective Longitudinal Study of First-Episode Schizophrenia

(2011) Nancy C. Andreasen et al.   BIOLOGICAL PSYCHIATRY

Can we combine symptom scales for collaborative research projects?

(2011) John P. Lyne et al.   JOURNAL OF PSYCHIATRIC RESEARCH

International Consensus Study of Antipsychotic Dosing

(2010) David M. Gardner et al.   AMERICAN JOURNAL OF PSYCHIATRY

Optimized voxel brain morphometry: association between brain volumes and the response to atypical antipsychotics

(2010) Vicente Molina et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Subcortical and cortical gray matter differences between Kraepelinian and non-Kraepelinian schizophrenia patients identified using voxel-based morphometry

(2010) Vicente Molina et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

The Effects of Antipsychotics on the Brain: What Have We Learnt from Structural Imaging of Schizophrenia? – A Systematic Review

(2009) R. Smieskova et al.   CURRENT PHARMACEUTICAL DESIGN

Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia

(2009) Luisa Tomelleri et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Distinct pattern of brain structural deficits in subsyndromes of schizophrenia delineated by psychopathology

(2009) Igor Nenadic et al.   NEUROIMAGE

Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings

(2009) S. Navari et al.   PSYCHOLOGICAL MEDICINE

Gray Matter in First-Episode Schizophrenia Before and After Antipsychotic Drug Treatment. Anatomical Likelihood Estimation Meta-analyses With Sample Size Weighting

(2009) M. Leung et al.   SCHIZOPHRENIA BULLETIN

Meta-Analysis of Gray Matter Anomalies in Schizophrenia: Application of Anatomic Likelihood Estimation and Network Analysis

(2008) David C. Glahn et al.   BIOLOGICAL PSYCHIATRY

Increased grey matter densities in schizophrenia patients with negative symptoms after treatment with quetiapine: a voxel-based morphometry study

(2008) Emmanuel Stip et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Differential clinical, structural and P300 parameters in schizophrenia patients resistant to conventional neuroleptics

(2007) V. Molina et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY